Product information

Current status:

Cancelled Post Market

Current status date:

2001-05-22

Original market date: ^{See footnote 1}

1997-08-11

Product name:

ACEL-P - SUS IM 300HAU

DIN:

02215071 Electronic product monograph is not available

Company:

LEDERLE LABS, DIVISION OF AMERICAN CYANAMID CO
401 North Middletown Road
Pearl River
New York
United States 10965

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

80:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

J07AJ02 PERTUSSIS, PURIFIED ANTIGEN

Active ingredient group (AIG) number:^{See footnote5}

0128535001